Dhannura S, Shekh S, Dhurjad P, Dolle A, Kakkat S, Vishwajyothi
ACS Omega. 2024; 9(36):37596-37609.
PMID: 39281945
PMC: 11391441.
DOI: 10.1021/acsomega.4c01028.
Turcio R, Di Matteo F, Capolupo I, Ciaglia T, Musella S, Di Chio C
Mar Drugs. 2024; 22(8).
PMID: 39195466
PMC: 11355921.
DOI: 10.3390/md22080350.
Wang C, Chen M, Lu X, Yang S, Yang M, Fang Y
Int J Mol Sci. 2023; 24(13).
PMID: 37446275
PMC: 10342134.
DOI: 10.3390/ijms241311097.
Groome J
Mar Drugs. 2023; 21(4).
PMID: 37103349
PMC: 10142487.
DOI: 10.3390/md21040209.
Fiorotti H, Figueiredo S, Campos F, Pimenta D
J Venom Anim Toxins Incl Trop Dis. 2023; 29:e20220052.
PMID: 36756364
PMC: 9897318.
DOI: 10.1590/1678-9199-JVATITD-2022-0052.
What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.
Straub C, Rusali L, Kremiller K, Riley A
J Med Chem. 2022; 66(1):107-121.
PMID: 36440853
PMC: 10034762.
DOI: 10.1021/acs.jmedchem.2c01562.
Integrating Venom Peptide Libraries Into a Phylogenetic and Broader Biological Framework.
Chase K, Watkins M, Safavi-Hemami H, Olivera B
Front Mol Biosci. 2022; 9:784419.
PMID: 35265668
PMC: 8899473.
DOI: 10.3389/fmolb.2022.784419.
Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors.
Bekbossynova A, Zharylgap A, Filchakova O
Molecules. 2021; 26(11).
PMID: 34204855
PMC: 8199771.
DOI: 10.3390/molecules26113373.
Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations.
Katz D, DiMattia M, Sindhikara D, Li H, Abraham N, Leffler A
Mar Drugs. 2021; 19(7).
PMID: 34202022
PMC: 8306581.
DOI: 10.3390/md19070367.
Non-Peptidic Small Molecule Components from Cone Snail Venoms.
Lin Z, Torres J, Watkins M, Paguigan N, Niu C, Imperial J
Front Pharmacol. 2021; 12:655981.
PMID: 34054536
PMC: 8155685.
DOI: 10.3389/fphar.2021.655981.
Structure-Function of Neuronal Nicotinic Acetylcholine Receptor Inhibitors Derived From Natural Toxins.
Ho T, Abraham N, Lewis R
Front Neurosci. 2020; 14:609005.
PMID: 33324158
PMC: 7723979.
DOI: 10.3389/fnins.2020.609005.
Animal toxins - Nature's evolutionary-refined toolkit for basic research and drug discovery.
Herzig V, Cristofori-Armstrong B, Israel M, Nixon S, Vetter I, King G
Biochem Pharmacol. 2020; 181:114096.
PMID: 32535105
PMC: 7290223.
DOI: 10.1016/j.bcp.2020.114096.
Raising the Bar On-Bead: Efficient On-Resin Synthesis of α-Conotoxin LvIA.
Kondasinghe T, Saraha H, Jackowski S, Stockdill J
Tetrahedron Lett. 2019; 60(1):23-28.
PMID: 31564757
PMC: 6764457.
DOI: 10.1016/j.tetlet.2018.11.048.
α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M, Valdes A, Christensen S, Tran P, Watkins M, Gajewiak J
Neuropharmacology. 2019; 157:107691.
PMID: 31255696
PMC: 6693646.
DOI: 10.1016/j.neuropharm.2019.107691.
Effects of C-Terminal Carboxylation on α-Conotoxin LsIA Interactions with Human α7 Nicotinic Acetylcholine Receptor: Molecular Simulation Studies.
Wen J, Hung A
Mar Drugs. 2019; 17(4).
PMID: 30987002
PMC: 6521072.
DOI: 10.3390/md17040206.
Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models.
Kryukova E, Ivanov I, Lebedev D, Spirova E, Egorova N, Zouridakis M
Mar Drugs. 2018; 16(12).
PMID: 30469507
PMC: 6315749.
DOI: 10.3390/md16120460.
Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
Hone A, Talley T, Bobango J, Huidobro Melo C, Hararah F, Gajewiak J
J Biol Chem. 2018; 293(46):17838-17852.
PMID: 30249616
PMC: 6240866.
DOI: 10.1074/jbc.RA118.005649.
Effect of Methionine Oxidation and Substitution of α-Conotoxin TxID on α3β4 Nicotinic Acetylcholine Receptor.
Ren J, Li R, Ning J, Zhu X, Zhangsun D, Wu Y
Mar Drugs. 2018; 16(6).
PMID: 29925760
PMC: 6025358.
DOI: 10.3390/md16060215.
Neuronal Nicotinic Acetylcholine Receptor Modulators from Cone Snails.
Abraham N, Lewis R
Mar Drugs. 2018; 16(6).
PMID: 29899286
PMC: 6024932.
DOI: 10.3390/md16060208.
Discovery of peptide ligands through docking and virtual screening at nicotinic acetylcholine receptor homology models.
Leffler A, Kuryatov A, Zebroski H, Powell S, Filipenko P, Hussein A
Proc Natl Acad Sci U S A. 2017; 114(38):E8100-E8109.
PMID: 28874590
PMC: 5617267.
DOI: 10.1073/pnas.1703952114.